Results 11 to 20 of about 1,499,834 (230)

Rosiglitazone for type 2 diabetes mellitus [PDF]

Cochrane Database of Systematic Reviews, 2006
Diabetes has long been recognised as a strong, independent risk factor for cardiovascular disease, a problem which accounts for approximately 70% of all mortality in people with diabetes. Prospective studies show that compared to their non-diabetic counterparts, the relative risk of cardiovascular mortality for men with diabetes is two to three and for
Karla Bergerhoff, Elizabeth Bandeira-Echtler, Susanne H Ebrahim, Christine Clar, Bernd Richter   +4 more
openaire   +3 more sources

Relationship Between Family Support and Diet Compliance in Diabetes Mellitus Patients Type 2 in Internal Disease Poly RSU Karsa Husada Batu

Jurnal Keperawatan dan Fisioterapi, 2022
Diabetes mellitus is a chronic disease which is one of the health problems in Indonesia with a prevalence of 24.49 million people. One of the management of diabetes mellitus is diet therapy.
Chindy Surya Kencana, Achmad Dafir Firdaus, Risna Yekti Mumpuni   +2 more
doaj   +1 more source

Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus

Current Diabetes Reports, 2022
Diabetes mellitus is a complex, chronic illness characterized by elevated blood glucose levels that occurs when there is cellular resistance to insulin action, pancreatic β-cells do not produce sufficient insulin, or both. Diabetes prevalence has greatly
Margarita Ortíz-Martínez, M. González‐González, Alexandro J. Martagon, Victoria Hlavinka, Richard C. Willson, M. Rito‐Palomares   +5 more
semanticscholar   +1 more source

Assessment of the operative memory capacity based on endogenous evoked potentials (P300 method) without neuropsychological testing

Анналы клинической и экспериментальной неврологии, 2017
We analyzed the dependence of the operative memory (OP) capacityon P300 parameters in healthy individuals and patientswith a varying degree of memory impairments.
V. V. Gnezditskiy, A. V. Chatskaya, O. S. Korepina, O. I. Klochkova   +3 more
doaj   +1 more source

The PPARγ2 P12A polymorphism is not associated with all-cause mortality in patients with type 2 diabetes mellitus [PDF]

, 2016
The high mortality risk of patients with type 2 diabetes mellitus may well be explained by the several comorbidities and/or complications. Also the intrinsic genetic component predisposing to diabetes might have a role in shaping the risk of diabetes ...
Alberico, Federica, Bacci, Simonetta, Cignarelli, Mauro, Copetti, Massimiliano, De Cosmo, Salvatore, Fontana, Andrea, Lamacchia, Olga, Marucci, Antonella, Mercuri, Luana, Pacilli, Antonio, Palena, Antonio, Prudente, Sabrina, Trischitta, Vincenzo, Viti, Raffaella   +13 more
core   +1 more source

Prevalence of lean type 2 diabetes mellitus in recently diagnosed type 2 diabetes mellitus patients

Indian Journal of Endocrinology and Metabolism, 2013
Introduction: Obesity has always been thought to be a risk factor for diabetes; however, some studies in India have reported that even lean people are prone to diabetes.
Prateek Chaudhary, Demitrost Laloo, Ranabir Salam   +2 more
doaj   +1 more source

Diabetes mellitus type 2 in adults

Сахарный диабет, 2020
Public organization “Russian Association of Endocrinologists”. Clinical guidelines. 
Ivan I. Dedov, Marina V. Shestakova, Alexander Y. Mayorov, Minara S. Shamkhalova, Olga Yu. Sukhareva, Gagik R. Galstyan, Alla Y. Tokmakova, Tatiana V. Nikonova, Elena V. Surkova, Irina V. Kononenko, Daria N. Egorova, Lyudmila I. Ibragimova, Ekaterina A. Shestakova, Inna I. Klefortova, Igor A. Sklyanik, Ivona Ya. Yarek-Martynova, Anastasia S. Severina, Sergey A. Martynov, Olga K. Vikulova, Viktor Y. Kalashnikov, Irina Z. Bondarenko, Irina S. Gomova, Elena G. Starostina, Alexander S. Ametov, Mikhail B. Antsiferov, Tatiana P. Bardymova, Irina A. Bondar, Farida V. Valeeva, Tatiana Y. Demidova, Ashot M. Mkrtumyan, Nina A. Petunina, Lyudmila A. Ruyatkina, Lyudmila A. Suplotova, Olga V. Ushakova, Yurii Sh. Khalimov   +34 more
doaj   +1 more source

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

New England Journal of Medicine, 2019
BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium-glucose cotransporter 2 (SGLT2), exploratory results have ...
V. Perkovic, M. Jardine, B. Neal, Severine Bompoint, H. Heerspink, D. Charytan, Robert Edwards, R. Agarwal, G. Bakris, S. Bull, C. Cannon, G. Capuano, P. Chu, D. de Zeeuw, T. Greene, A. Levin, C. Pollock, D. Wheeler, Yshai Yavin, Hong Zhang, B. Zinman, G. Meininger, B. Brenner, K. Mahaffey   +23 more
semanticscholar   +1 more source

Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management

Cardiovascular Diabetology, 2022
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly in low- and middle-income countries. To effectively prevent the development of CVDs in T2DM, considerable effort has been made to
Cheng-Xu Ma, Xiaoni Ma, C. Guan, Ying-dong Li, D. Mauricio, S. Fu   +5 more
semanticscholar   +1 more source

Facilitators and barriers of adaptation to diabetes: experiences of Iranian patients [PDF]

, 2014
Background: Diabetes mellitus is one of the most challenging and burdensome chronic diseases of the 21st century and More than 1% of the Iranian urban population older than 20 years develops Type 2 diabetes each year.
Arshadi Bostanabad, M., Jouybari, L., Karimi Moonaghi, H., McDonald, H., Namdar Areshtanab, H.   +4 more
core   +2 more sources